Quantitation of McArdle's Sign and Evaluation of Specificity for Multiple Sclerosis

Overview

  • Study type

    Observational
  • Study IDs

  • Describes the nature of a clinical study. Types include:

    • Observational study — observes people and measures outcomes without affecting results.
    • Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
    • Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
  • Site IRB
    • Rochester, Minnesota: 15-009122
    NCT ID: NCT03122873
    Sponsor Protocol Number: 15-009122

About this study

The study is designed to quantitate McArdle's sign, an increase in measurable weakness with neck flexion described in patients with multiple sclerosis, and to determine whether it is or is not specific for multiple sclerosis.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

See eligibility criteria

Inclusion Criteria:

  • Myelopathy of any cause with finger extension weakness
  • Patients with peripheral neuropathy with finger extension weakness
  • Healthy controls

Exclusion Criteria:

  • Pregnant subjects.

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Brian Weinshenker, M.D.

Closed for enrollment

Contact information:

Adriana Delgado CCRP

(507)538-1440

Delgado.Adriana@mayo.edu

.
CLS-20260179

Mayo Clinic Footer